Transcription factor AP-2B as a potential therapeutic target and diagnostic biomarkers for monoaminergic neurotransmitter disorders. READ MORE HERE https://t.co/qca9sQtJKQ #Alzheimers #obesity #diabetes #Neuroblastoma #SPHT22 https://t.co/YoLEtGaxUo
RT @OACellBiology: The regulatory role of AP-2β in monoaminergic neurotransmitter systems: insights on its signalling pathway, linked disor…
https://t.co/SEIKy4zlQy Our new review article is out. IF 9.5. The review elaborates on AP-2B and its theragnostic potential in Neuroblastoma and obesity. #transcription_factor, #obesity, #drugtarget #noradrenaline, #serotonin #dopamine, #alzheimer, #
The regulatory role of AP-2β in monoaminergic neurotransmitter systems: insights on its signalling pathway, linked disorders and theragnostic potential https://t.co/dWZtfYuym1